Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic value of platelet-to-lymphocyte ratio in pancreatic cancer: a comprehensive meta-analysis of 17 cohort studies
Yongping Zhou, Sijin Cheng, Abdel Hamid Fathy, et al.
OncoTargets and Therapy (2018) Vol. Volume 11, pp. 1899-1908
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies
Meghan A. Cupp, Margarita Cariolou, Ioanna Tzoulaki, et al.
BMC Medicine (2020) Vol. 18, Iss. 1
Open Access | Times Cited: 435
Prognostic value of the neutrophil‑lymphocyte, platelet‑lymphocyte and monocyte‑lymphocyte ratio in breast cancer patients
Joanna Huszno, Zofia Kołosza
Oncology Letters (2019)
Open Access | Times Cited: 54
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
Andrii Khomiak, Marius Brunner, Maximilian Kordes, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3234-3234
Open Access | Times Cited: 49
Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer—What Can We Learn from the Hematological Experience?
Øystein Bruserud, Helene Hersvik Aarstad, Tor Henrik Anderson Tvedt
Cancers (2020) Vol. 12, Iss. 7, pp. 1966-1966
Open Access | Times Cited: 47
Systemic immune-inflammation index: a prognostic tiebreaker among all in advanced pancreatic cancer
Alessandro Bittoni, Federica Pecci, Giulia Mentrasti, et al.
Annals of Translational Medicine (2021) Vol. 9, Iss. 3, pp. 251-251
Open Access | Times Cited: 32
The Combination of Neutrophil–Lymphocyte Ratio and Platelet–Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer
Marta Toledano‐Fonseca, María Teresa Cano, Elizabeth Inga, et al.
Cancers (2021) Vol. 13, Iss. 6, pp. 1210-1210
Open Access | Times Cited: 28
Serum hsa-miR-22-3p, hsa-miR-885-5p, Lipase-to-Amylase Ratio, C-Reactive Protein, CA19-9, and Neutrophil-to-Lymphocyte Ratio as Prognostic Factors in Advanced Pancreatic Ductal Adenocarcinoma
Jakub Wnuk, Dorota Hudy, Joanna Katarzyna Strzelczyk, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 1, pp. 27-27
Open Access
Baseline neutrophil-to-lymphocyte ratio (NLR) at the time of diagnosis of liver metastasis is an independent prognostic factor for patients with pancreatic cancer liver metastasis (PCLM)
H. Huang, Wencheng Yin, Hua Zhang, et al.
Research Square (Research Square) (2025)
Open Access
Prognostic Significance of C-reactive protein or Prealbumin in Pancreatic Ductal Adenocarcinoma
Guo Yu, Yan Dou, Xi Ma, et al.
Journal of Surgical Research (2025) Vol. 306, pp. 543-553
Closed Access
Prognostic Impacts of Depression and Inflammatory Factors in Pancreatic Cancer Patients
Pisin Chen, Yang-Chen Shen, Cheng‐Feng Lin, et al.
(2025) Vol. 87, Iss. 2, pp. 146-152
Closed Access
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
Denise Bernhardt, Sophie Aufderstrasse, Laila König, et al.
Cancer Management and Research (2018) Vol. Volume 10, pp. 6563-6569
Open Access | Times Cited: 36
Biomarkers for Malignant Pleural Mesothelioma—A Novel View on Inflammation
Melanie Vogl, Anna Rosenmayr, T Bohanes, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 658-658
Open Access | Times Cited: 25
Prognostic Significance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratio in Rectal Cancer: A Systematic Review, Meta-analysis, and Meta-regression
Hytham K. S. Hamid, Sameh Hany Emile, George Neelankavil Davis
Diseases of the Colon & Rectum (2021) Vol. 65, Iss. 2, pp. 178-187
Closed Access | Times Cited: 23
Model for end-stage liver disease-dependent prognostic capacity of platelet-to-lymphocyte ratio following liver transplantation for hepatocellular carcinoma
Chiyu He, Weiliang Shen, Zuyuan Lin, et al.
Transplant Immunology (2024) Vol. 85, pp. 102071-102071
Closed Access | Times Cited: 3
Hypofractionated radiotherapy plus PD-1 antibody and SOX chemotherapy as second-line therapy in metastatic pancreatic cancer: a single-arm, phase II clinical trial
Qin Wang, Fan Tong, Qiao Li, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 10
Open Access | Times Cited: 3
Pretreatment C-reactive protein/albumin ratio for predicting overall survival in pancreatic cancer
Ye Zang, Yu Fan, Zhenjun Gao
Medicine (2020) Vol. 99, Iss. 23, pp. e20595-e20595
Open Access | Times Cited: 24
The role of systemic immuno-inflammatory factors in resectable pancreatic adenocarcinoma: a cohort retrospective study
Diana Schlanger, Călin Popa, Sergiu P. Paşca, et al.
World Journal of Surgical Oncology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 14
Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer
Yueming Zhang, Yaolin Xu, Dansong Wang, et al.
International Journal of Clinical Oncology (2020) Vol. 26, Iss. 1, pp. 135-144
Closed Access | Times Cited: 23
Inflammation-Based Prognostic Scores in Pancreatic Cancer Patients—A Single-Center Analysis of 1294 Patients within the Last Decade
Christopher Neumann, F Schneider, Georg Hilfenhaus, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2367-2367
Open Access | Times Cited: 7
Prognostic role of platelet-to-lymphocyte ratio in patients with rectal cancer undergoing resection: a systematic review and meta-analysis
Lijuan Ma, Fei Yang, Wentao Guo, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemotherapy
Shuichi Ota, Mamiko Miyashita, Yuka Yamagishi, et al.
Human Vaccines & Immunotherapeutics (2021) Vol. 17, Iss. 12, pp. 5563-5572
Open Access | Times Cited: 16
The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment
Toru Aoyama, MIWA JU, KEISUKE KOMORI, et al.
In Vivo (2022) Vol. 36, Iss. 4, pp. 1916-1922
Open Access | Times Cited: 10
High Systemic Immune-Inflammation Index and Body Mass Index Are Independent Risk Factors of the Thoracic Ossification of the Ligamentum Flavum
Yongzhao Zhao, Qian Xiang, Jialiang Lin, et al.
Mediators of Inflammation (2022) Vol. 2022, pp. 1-7
Open Access | Times Cited: 10
Prognostic significance of STIP1 expression in human cancer: A meta-analysis
Shupeng Zhang, Jianping Shao, Feng Su
Clinica Chimica Acta (2018) Vol. 486, pp. 168-176
Closed Access | Times Cited: 18
The Prognostic Role of Glasgow Prognostic Score and C-reactive Protein to Albumin Ratio for Sarcoma: A System Review and Meta-Analysis
Erhu Fang, Xiaolin Wang, Jiexiong Feng, et al.
Disease Markers (2020) Vol. 2020, pp. 1-14
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top